Kyly Clarke urges Aussies to step up to save lives from melanoma

Kyly Clarke urges Aussies to step up to save lives from melanoma

3 February 2020

Australian television presenter, interior designer and mother Kyly Clarke has been announced as the new Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign Melanoma March.

Kyly toured Melanoma Institute Australia’s world-leading research and treatment centre where she met CEO Matthew Browne and Co-Medical Directors Professor Georgina Long and Professor Richard Scolyer. Kyly also met families devastated by melanoma, including Jen Benfield who has survived the disease, and the El-Hourani family, who sadly lost their mum and wife Kerry to melanoma.  

Kyly knows too well the personal impact of melanoma, with her own grandmother dying from the disease and herself having a melanoma scare.

‘I sadly never had the chance to meet my grandmother who died from melanoma before I was born,’ said Kyly. ‘Her death had such an impact on my family that I have always been extremely vigilant about checking my own skin for changes.

‘When I noticed one of my moles was changing, I sought medical advice and it was removed. Given my family history of melanoma, it was a tough week waiting for results to come back but luckily it was an abnormal mole rather than a melanoma.

‘I want my daughter Kelsey Lee to grow up in a world where sun safe behaviour is the norm and where there are effective treatments to save lives from melanoma, which is why I am delighted to be helping raise awareness and funds to help tackle this health issue facing all Australians,’ she said.

MIA CEO Matthew Browne said the organisation was excited to have Kyly supporting Melanoma March which raises awareness about melanoma prevention and early detection as well as money for life saving research to find new and effective treatments for the disease.

‘Clinical advances in recent years have tripled life expectancy for some advanced melanoma patients, but the sad reality is we still have one Australian dying every five hours from melanoma,’ Mr Browne said.

‘To reach our goal of zero deaths from melanoma we need to continue our research effort unabated and that is why Melanoma March is so important for all Australians to support.’

‘It may also come as a surprise to many that melanoma is the most common cancer affecting 15 to 39 year old Australians and that sunburn, particularly during childhood, is the greatest risk factor for developing melanoma,’ Mr Browne added. ‘We are so grateful for Kyly’s support in helping raise awareness amongst young Australians and young families that living a sun safe life NOW is vitally important.’

Australia has the highest melanoma rate in the world with one Australian diagnosed with the disease every half an hour. Early detection is vital, as 90% of melanomas can be cured with surgery alone if caught early.

‘Like all Australians, our family loves the great outdoors, but it is important we enjoy our beautiful climate safely to protect our skin from the damaging effects of the sun and reduce our risk of developing all skin cancers, including melanoma,’ Kyly said.

‘It is equally important that we are vigilant about checking our skin for changes, and if by sharing my story I can encourage just one family to be sun safe and to keep an eye on their skin, then I am helping make a difference.

‘I’d urge all families to join their local Melanoma March to help raise awareness as well as much-needed funds for research so that one day no one will die from melanoma.’

For more information on how to register for a march near you or donate to Melanoma March, click on link: Melanoma March.

 

A meeting of the minds
02 Jun 2016

A meeting of the minds

MIA's doctors are converging on Chicago this week along with 40,000 delegates from around the globe at the biggest oncology conference in the world.

MIA's Dermatology services expanded
27 May 2016

MIA's Dermatology services expanded

We are pleased to announce a recent expansion to the dermatology services at Melanoma Institute Australia.

5 Minutes with Maria Gonzalez
20 May 2016

5 Minutes with Maria Gonzalez

This International Clinical Trials Day we reflect on the importance of clinical trials and the people who dedicate their lives to helping melanoma patients today and in the future.

Melanoma eBook to educate GPs
12 May 2016

Melanoma eBook to educate GPs

MIA has launched its first eBook Melanoma Essentials – A Concise Guide, a resource for GPs and other medical, nursing and allied professionals to help them effectively diagnose and manage cases.

5 Minutes with Dr Scot Ebbinghaus
05 May 2016

5 Minutes with Dr Scot Ebbinghaus

Dr Scot Ebbinghaus chats to us about an exciting clinical trial at MIA and where melanoma treatment is headed in the future.

Opdivo available on PBS for advanced melanoma patients
01 May 2016

Opdivo available on PBS for advanced melanoma patients

A new melanoma treatment has been listed on the PBS today, giving another option for advanced melanoma patients. 

5 Minutes with Dr Louise Jackett
27 Apr 2016

5 Minutes with Dr Louise Jackett

MIA's Pathology Fellow Dr Louise Jackett tells us why she's joined our fellowship program to learn from the best.

MIA patient's plight highlighted in ABC series
27 Apr 2016

MIA patient's plight highlighted in ABC series

MIA doctors and patient have featured in the final episode of ABC’s ground-breaking series Keeping Australia Alive.

Recruiting: Pregnancy and moles study
26 Apr 2016

Recruiting: Pregnancy and moles study

Specialist dermatologists at MIA are researching moles during pregnancy and we are looking for study recruits.

The role of radiotherapy in melanoma
22 Apr 2016

The role of radiotherapy in melanoma

New research is re-writing the textbooks on what we know about melanoma by highlighting the effectiveness of radiotherapy as a treatment, reversing a long-held belief that melanoma was resistant to radiotherapy.

Australian melanoma rates take the silver – and that's good news
31 Mar 2016

Australian melanoma rates take the silver – and that's good news

However, Australia's burden of melanoma will stay very high over the next 15 years unless we do more. MIA's Professor Graham Mann explains.

Australia unites taking small steps to make a big difference for melanoma research
23 Mar 2016

Australia unites taking small steps to make a big difference for melanoma research

Thank you to everyone involved in making Melanoma March 2016 a huge success

And they're off... Melanoma March 2016 begins!
29 Feb 2016

And they're off... Melanoma March 2016 begins!

Melanoma March 2016 has officially begun with more than 300 people marching in Rockingham and Devonport.

5 Minutes with Carole Renouf
29 Feb 2016

5 Minutes with Carole Renouf

MIA's new CEO Carole Renouf has been in her role only a month, but is already making plans for the future of MIA.

Opinion: Outing Melanoma
24 Feb 2016

Opinion: Outing Melanoma

In the wake of Susie Maroney's recent announcement that she is battling melanoma, CEO Carole Renouf's opinion piece weighs in on the critical need we have in Australia to raise awareness about melanoma. 

Congratulations Professor Georgina Long
22 Feb 2016

Congratulations Professor Georgina Long

MIA's Georgina Long has been appointed Professor and awarded a coverted prize in medial research.

Melanoma March 2016: Where your funds are going
19 Feb 2016

Melanoma March 2016: Where your funds are going

Melanoma March 2016 funding will be used to initiate an ambitious new project that will support the best possible care for melanoma patients around Australia through a new data and communication platform. 

New research shows long-term survival in group of advanced melanoma patients treated with BRAF inhibitors
05 Feb 2016

New research shows long-term survival in group of advanced melanoma patients treated with BRAF inhibitors

New MIA-led research has been published in the Journal of Clinical Oncology.

Melanoma March 2016 is launched
02 Feb 2016

Melanoma March 2016 is launched

Melanoma March was officially launched today with the announcement of the national research project funded by the march. 

MIA's research pivotal in TGA's approval of new therapy
01 Feb 2016

MIA's research pivotal in TGA's approval of new therapy

Clinical research undertaken at MIA has been pivotal in supporting the recent Therapeutic Goods Administration approval of Opdivo (nivolumab) for advanced melanoma.